Tag Archives: Mark Massaro

Heska Corp (HSKA) Receives a Rating Update from a Top Analyst

Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Heska Corp (HSKA – Research Report) yesterday and set a price target of $75. The company’s shares closed last Monday at $64.17, close to its 52-week low of $63.41. Massaro

Canaccord Genuity Maintains a Buy Rating on Natera (NTRA)

Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Natera (NTRA – Research Report) yesterday and set a price target of $38. The company’s shares closed last Monday at $30.55, close to its 52-week high of $33.55. Massaro commented:

Exact Sciences (EXAS) Receives a Rating Update from a Top Analyst

Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Exact Sciences (EXAS – Research Report) yesterday and set a price target of $135. The company’s shares closed last Monday at $108.74. Massaro said: “We are buyers of EXAS following

Orasure Technologies (OSUR) Receives a Rating Update from a Top Analyst

Canaccord Genuity analyst Mark Massaro maintained a Hold rating on Orasure Technologies (OSUR – Research Report) yesterday and set a price target of $7. The company’s shares closed last Monday at $7.57, close to its 52-week low of $7.15. Massaro

HTG Molecular Diagnostics (HTGM) Gets a Buy Rating from Canaccord Genuity

In a report released yesterday, Mark Massaro from Canaccord Genuity maintained a Buy rating on HTG Molecular Diagnostics (HTGM – Research Report), with a price target of $3. The company’s shares closed yesterday at $1.10, close to its 52-week low

Canaccord Genuity Believes Natera (NASDAQ: NTRA) Won’t Stop Here

Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Natera (NTRA – Research Report) yesterday and set a price target of $36. The company’s shares closed yesterday at $27.09, close to its 52-week high of $29.62. Massaro observed: “We